scholarly journals Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signaling

2021 ◽  
Author(s):  
Shuhui Lim ◽  
Nicolas Boyer ◽  
Nicole Boo ◽  
Chunhui Huang ◽  
Gireedhar Venkatachalam ◽  
...  
Keyword(s):  
Small Molecules ◽  
Protein Interactions ◽  
Therapeutic Targets ◽  
Protein Protein Interactions ◽  
Intracellular Protein ◽  
Macrocyclic Peptides

Macrocyclic peptides have the potential to address intracellular protein-protein interactions (PPIs) of high value therapeutic targets that have proven largely intractable to small molecules. Here, we report broadly applicable lessons...

scholarly journals Macrocycles as protein–protein interaction inhibitors

2017 ◽  
Vol 474 (7) ◽  
pp. 1109-1125 ◽  
Author(s):  
Patrick G. Dougherty ◽  
Ziqing Qian ◽  
Dehua Pei
Keyword(s):  
Small Molecules ◽  
Protein Interactions ◽  
Cyclic Peptides ◽  
Macrocyclic Compounds ◽  
Protein Protein Interactions ◽  
Intracellular Protein ◽  
Drug Candidates ◽  
Protein Protein Interaction ◽  
The Past ◽  
Conventional Drug

Macrocyclic compounds such as cyclic peptides have emerged as a new and exciting class of drug candidates for inhibition of intracellular protein–protein interactions, which are challenging targets for conventional drug modalities (i.e. small molecules and proteins). Over the past decade, several complementary technologies have been developed to synthesize macrocycle libraries and screen them for binding to therapeutically relevant targets. Two different approaches have also been explored to increase the membrane permeability of cyclic peptides. In this review, we discuss these methods and their applications in the discovery of macrocyclic compounds against protein–protein interactions.

scholarly journals Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules

MedChemComm ◽  
2017 ◽  
Vol 8 (12) ◽  
pp. 2216-2227 ◽  
Author(s):  
Wiktoria Jedwabny ◽  
Szymon Kłossowski ◽  
Trupta Purohit ◽  
Tomasz Cierpicki ◽  
Jolanta Grembecka ◽  
...  
Keyword(s):  
Small Molecules ◽  
Binding Affinity ◽  
Protein Interactions ◽  
Empirical Model ◽  
Inhibitory Activity ◽  
Theoretical Models ◽  
Mixed Lineage Leukemia ◽  
Protein Protein Interactions ◽  
Model Based ◽  
Dispersion Terms

A computationally affordable, non-empirical model based on electrostatic multipole and dispersion terms successfully predicts the binding affinity of inhibitors of menin–MLL protein–protein interactions.

Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy

2010 ◽  
Vol 86 (1) ◽  
pp. A32
Author(s):  
Alba Chimirri ◽  
Laura De Luca ◽  
Stefania Ferro ◽  
Rosaria Gitto ◽  
Anna Maria Monforte ◽  
...  
Keyword(s):  
Small Molecules ◽  
Protein Interactions ◽  
Protein Protein Interactions ◽  
Anti Hiv

scholarly journals Developing drugs for the ‘undruggable’

BioTechniques ◽  
2020 ◽  
Vol 69 (4) ◽  
pp. 239-241
Author(s):  
Abigail Sawyer
Keyword(s):  
Protein Interactions ◽  
Therapeutic Targets ◽  
Protein Protein Interactions ◽  
Human Interactome ◽  
Novel Therapeutic

There are up to 650,000 ‘undruggable’ protein-protein interactions (PPIs) in the human interactome that can be potentially considered as novel therapeutic targets. How does the ‘undruggable’ become ‘druggable’?

Assessing the cellular toxicity of peptide inhibitors of intracellular protein-protein interactions by microinjection

2021 ◽  
Vol 29 ◽  
pp. 115906
Author(s):  
Sanjeevini Babu Reddiar ◽  
Hareth Al-Wassiti ◽  
Colin W. Pouton ◽  
Cameron J. Nowell ◽  
Macgregor A. Matthews ◽  
...  
Keyword(s):  
Protein Interactions ◽  
Peptide Inhibitors ◽  
Protein Protein Interactions ◽  
Intracellular Protein ◽  
Cellular Toxicity
Sign in / Sign up

Export Citation Format

Share Document